A new code for an old SaaS brand hits the ASX today when the ShareRoot (ASX:SRO) brand retires, replaced by Opyl Ltd (ASX:OPL).
Melbourne-based Opyl uses AI-assisted tech to help biopharma and health organisations collect and analyse clinical health data and user-generated content, including from wearables, apps and social media, to better understand and improve healthcare design, development and delivery.
Opyl’s co-founder Michelle Gallaher (pictured above), who became CEO earlier this year, has led the rebranding and shift in focus to digital health and artificial intelligence (AI) since it was founded in California in 2013, and listed in 2016.
Gallaher said analysing social media and patient-generated data offers the “final piece of the puzzle” to understand the lived experience of people managing illness, injury and disorders.
“Hearing millions of patients’ and carers’ voices for the first time-in their own words shared to social media platforms is an extraordinary insight that few in the health sector have been able to access until now,” she said.
“Patient stories and information shared to social networks gives us an ability to understand what their needs are and how they are not being met, identifying gaps where new technologies can be developed, predict the spread of infectious diseases, identify shortcomings in health and wellness education, improve compliance, identify new clinical intervention opportunities and opening up a novel way for patients to participate in medical research as partners.”
Gallaher said the company only uses publicly available information when a patient or carer consents.
“Our vision is to give patients control and agency over all their health data, not just electronic health records,” she said.
Gallaher said it felt like the business was “wearing clothes that didn’t fit, giving the wrong impression of who we are” as it moved from martech into data analytics in health over the last six months under the old name, hence the rebrand.
“Digital and data technologies will play an increasingly disruptive role in transforming health, clinical research and activating patients to be partners in their health care,” she said.
“We are very excited at the addition of AI-powered technologies to the STEMM-specialist social media content creation and management services we currently offer.”
Melbourne design studio, Malt Creative, worked with Opyl’s internal design team to develop the company’s new brand.